TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-2 DIFFERENTIALLY AFFECT HIPPOCAMPAL SEROTONERGIC NEUROTRANSMISSION, BEHAVIORAL ACTIVITY, BODY-TEMPERATURE AND HYPOTHALAMIC-PITUITARY-ADRENOCORTICAL AXIS ACTIVITY IN THE RAT
S. Pauli et al., TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-2 DIFFERENTIALLY AFFECT HIPPOCAMPAL SEROTONERGIC NEUROTRANSMISSION, BEHAVIORAL ACTIVITY, BODY-TEMPERATURE AND HYPOTHALAMIC-PITUITARY-ADRENOCORTICAL AXIS ACTIVITY IN THE RAT, European journal of neuroscience, 10(3), 1998, pp. 868-878
Intraperitoneal endotoxin injection and central administration of inte
rleukin (IL)-1 beta profoundly activate hippocampal serotonergic neuro
transmission. This study was designed to investigate, using in vivo mi
crodialysis, the effects of another endotoxin-induced proinflammatory
cytokine, tumour necrosis factor-alpha, and the effects of the non-inf
lammatory cytokine, IL-2, on hippocampal extracellular levels of serot
onin, To compare the effects of these cytokines on neurotransmission w
ith the effects on physiological parameters and behaviour, hypothalami
c-pituitary-adrenocortical (HPA) axis activity, body temperature and b
ehavioural activity were monitored as well, Time-dependent changes in
serotonergic neurotransmission and HPA axis activity were determined b
y measuring serotonin, its metabolite 5-hydroxyindoleacetic acid and f
ree corticosterone in dialysates, Total behavioural activity was score
d by assessing the time during which rats were active. Core body tempe
rature was measured by biotelemetry. Intracerebroventricular injection
of 50 or 100 ng recombinant murine tumour necrosis factor-alpha exert
ed no effect on hippocampal serotonergic neurotransmission, and induce
d no signs of sickness behaviour. However, these doses produced a dose
-dependent increase in body temperature and free corticosterone levels
. In contrast, intracerebroventricular administration of 500 ng, but n
ot of 50 ng, recombinant human IL-2 produced a marked increase in hipp
ocampal extracellular concentrations of serotonin and 5-hydroxyindolea
cetic acid, accompanied by a pronounced behavioural inhibition and oth
er signs of sickness. Moreover, both doses of IL-2 caused a dose-depen
dent increase in body temperature and free corticosterone levels. Inte
restingly, intracerebroventricular pretreatment with the IL-1 receptor
antagonist showed that the effects of IL-2 on hippocampal serotonin w
ere completely dependent on endogenous brain IL-1. However, IL-1 seeme
d to play only a minor role in the IL-2-induced increase in free corti
costerone. Taken together, the results show that cytokines produce par
tially overlapping brain-mediated responses, but are selectively effec
tive in stimulating hippocampal serotonergic neurotransmission and ind
ucing sickness behaviour, Moreover, we postulate that activation of hi
ppocampal serotonin release is instrumental in the full development of
behavioural inhibition.